INSM Q1 2019 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M

Gross Profit

$18M81.1% margin

Operating Income

-$70M-317.4% margin

Net Income

-$74M-338.6% margin

EPS (Diluted)

$-0.96

QoQ Revenue Growth

+122.7%

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$78M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$596M

Total Liabilities

$452M

Stockholders' Equity

$144M

Cash & Equivalents

$420M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$0	—
Gross Profit	$18M	$0	—
Operating Income	-$70M	-$63M	-10.8%
Net Income	-$74M	-$69M	-8.2%